Table 2.
How to improve access to HCT
| Target | Topic | Actions |
|---|---|---|
| Benchmarking activities among countries and regions | Global HCT activity reports | Biannual survey since 20064,6,47-50 |
| Starting new programs | Alerting health authorities and politicians about the need for programs in countries with low HCT activity | Organization of WBMT workshops in cooperation with the WHO51 |
| Essential medication | Published previously52 | |
| Training of physicians, nurses, technicians, and data managers | Scientific societies; accredited transplant centers | |
| Infrastructure | Define essential infrastructure37,53 | |
| Site visit from experienced physicians | Role of scientific societies | |
| Financial aspects | Optimize treatment | |
| Twinning and telemedicine | Supervisory telemedicine42 | |
| Optimizing existing programs | Outcome registries | Establish outcome registries Analysis of different techniques54 |
| Accreditation | Liaise with JACIE/FACT | |
| Utilization of HCT worldwide | Analyzing incidence (tumor registries) and HCT activities for each disease in regions and countries55 | |
| Establishing alternate donor registries | Describe challenges in developing countries56 | |
| Establishing clinical studies | Structures for local registries, noninterventional, interventional studies |
FACT, Foundation for the Accreditation of Cellular Therapy; JACIE, Joint Accreditation Committee of the International Society for Cellular Therapy.